You share your eye care provider's concerns about scleral lenses. It is important to note that any treatment or product can be associated with adverse effects, particularly if it is not administered or used appropriately. We cannot speak to the effectiveness of scleral lenses fitted by other providers, but we can say that the ability to successfully replace or support impaired ocular surface system functions, reduce symptoms and improve vision is determined by three interdependent factors:
- The individual patient's needs, functional goals and capabilities
- The specific underlying condition(s) being treated and desired treatment outcomes
- The success of the fit- which is determined by the expertise and skill of the treatment team interfaced with the effectiveness/flexibility of the technology/tools/materials required to design and manufacture the devices or lenses
As Rebecca mentioned, BFS and our PROSE Clinic partners have treated over 1,000 patients with dry eye over the last 19 years. The devices used in PROSE have been approved by the FDA since 1994 for the treatment of ectasia and ocular surface disease (including dry eye). We have over 40 peer-reviewed research papers, publications and talks documenting the effectiveness of our treatment. Please visit www.bostonsight.org/research for a complete list, but one relevant piece of research from the American Journal of Ophthalmology shows that PROSE "significantly improved VA [visual acuity] and visual functioning in patients with corneal ectasia, irregular astigmatism, and ocular surface disease who had failed conventional therapies."
PROSE treatment has also gained wide recognition and acceptance within the world of ophthalmology and optometry. PROSE is currently provided by 12 top-ranked academic medical centers in the US and clinics abroad; including the Doheny Eye Institute at USC in Los Angeles, CA (ranked #9 in the US by their peers) and the Alkek Eye Center, formerly the Cullen Eye Institute, at Baylor College of Medicine in Houston, TX (ranked #14). Additionally, in 2010 almost 80% of patients treated with PROSE at BFS had their treatment covered by insurance and/or financial assistance.
In addition to all of our bona fides, please let me connect you directly to our New Patient Affairs Coordinator, Nancy Lemist:
Hello Dry Eye Zone members. I wanted to take this opportunity to introduce myself to the DEZ community personally. I have been with BFS for almost two years and recently took on the role of New Patient Affairs Coordinator.
As many of you are probably aware, every patient is entitled to request medical notes from his/her doctors. In terms of our intake process for PROSE treatment, we ask patients for EITHER a referral from their eye care provider or specialist OR, if that is not possible, the last medical note from their eye care provider. If you or your doctor are uncertain about the potential benefits of PROSE for your specific condition, you may find it helpful to get a second opinion before moving forward.
In response to NeedHelp640 specifically, I am sorry that you did not get a reply from us when you last called. I would be happy to answer any questions you have regarding BFS or our treatment. And if you would like to pursue a second opinion, I can try to help you locate a doctor in your area that is familiar with PROSE treatment.
Thank you and please let me know if I can help answer any other questions.
New Patient Affairs Coordinator
Boston Foundation for Sight